attachment
attachment

Answer

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Excellent - I now have everything needed for a complete, authoritative answer. Here it is:

Clinical Scenario: 18-month-old with jaundice, diarrhea, cataract, hepatomegaly, delayed milestones + positive Benedict's test


1. Probable Diagnosis: Classic Galactosemia (Type I)

This is a textbook presentation of galactosemia - an autosomal recessive disorder of galactose metabolism.
The key clues that point to this diagnosis:
Feature in CaseExplanation
Jaundice + hepatomegalyGalactose-1-phosphate accumulates in liver → fatty change → cirrhosis
Diarrhea + failure to thriveBegins within days of milk (lactose) ingestion
Bilateral cataractsGalactitol accumulates in lens → osmotic swelling → lens opacity
Delayed developmental milestonesCNS damage (dentate nuclei, cerebral cortex) from toxic metabolite accumulation
Positive Benedict's testGalactose is a reducing sugar - excreted in urine → gives a positive result with Benedict's reagent
The positive Benedict's test is particularly diagnostic: galactose is a reducing sugar that reacts with Benedict's reagent (copper sulfate in alkaline medium), turning it brick-red/orange. Note that this test is non-specific for glucose (it detects all reducing sugars), which is why it's used here - a glucose-specific test like glucose oxidase would be negative in galactosemia.

2. Deficient Enzyme: Galactose-1-phosphate uridyl transferase (GALT)

This is the enzyme deficient in Classic Galactosemia (Type I). There are three recognized variants:
FormEnzyme DeficientKey Feature
Type I (Classic)Galactose-1-phosphate uridyl transferase (GALT)Full syndrome: jaundice, hepatomegaly, cataracts, intellectual disability, sepsis
Type IIGalactokinaseCataracts only (milder)
Type IIIUDP-galactose-4-epimeraseVariable severity
This child has the full classic triad (jaundice + hepatomegaly + cataracts + developmental delay) → GALT is deficient.

3. Biochemical Basis of the Disease

The normal galactose metabolism pathway:
Lactose → (lactase) → Glucose + Galactose
                                    ↓
                         Galactokinase
                                    ↓
                        Galactose-1-phosphate
                                    ↓
                    GALT (DEFICIENT in Classic Galactosemia)
                                    ↓
                         Glucose-1-phosphate → enters glycolysis
When GALT is absent or severely deficient:
  1. Galactose-1-phosphate accumulates in liver, spleen, lens, kidneys, brain, red cells - this is directly cytotoxic.
  2. Alternative pathways are activated:
    • Galactose → (aldose reductase) → Galactitol - accumulates in lens → draws water osmotically → cataracts
    • Galactose → Galactonate (oxidized by-product) - also accumulates in tissues
  3. Organ-specific toxicity:
    • Liver: fatty change early → cirrhosis later → jaundice + hepatomegaly
    • Lens: galactitol osmotic accumulation → cataracts within weeks
    • Brain: loss of neurons, gliosis, edema (dentate nuclei of cerebellum + olivary nuclei of medulla) → developmental delay
    • Kidney: galactose-1-phosphate impairs tubular amino acid transport → aminoaciduria
  4. Urine: galactose is excreted as a reducing sugar → positive Benedict's test (but negative glucose oxidase strip test - an important distinguishing feature)

Key Additional Points

  • Diagnosis confirmed by: Fluorometric assay of GALT enzyme activity on dried blood spot; confirmed by GALT assay in red cells
  • Treatment: Immediate removal of galactose/lactose from diet - switch to soy-based formula. Galactose restriction must be started as soon as the diagnosis is suspected
  • Prognosis: Early dietary restriction prevents cataracts and liver damage and allows near-normal development. However, even with strict diet, long-term complications include speech/verbal dyspraxia, motor abnormalities, and premature ovarian failure (hypergonadotropic hypogonadism) in females
  • Inheritance: Autosomal recessive (GALT gene mutation)

Sources: Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 440; Brenner and Rector's The Kidney, pp. 1941-1942; Harrison's Principles of Internal Medicine 22E
This is a shared conversation. Sign in to Orris to start your own chat.